ERBB2 c.1568C>T ;(p.P523L)

Variant ID: 17-37872608-C-T

NM_004448.2(ERBB2):c.1568C>T;(p.P523L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV non-small-cell lung cancer: A retrospective study.

Clinics (Sao Paulo, Brazil)
Lan, Yan Y; Zhou, Shuo S; Feng, Weihong W; Qiao, Ying Y; Du, Xueming X; Li, Fenge F
Publication Date: 2021

Variant appearance in text: HER2: P523L
PubMed Link: 33787673
Variant Present in the following documents:
  • cln-76-2251.pdf
View BVdb publication page



Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications.

Oncotarget
Toss, Angela A; Piacentini, Federico F; Cortesi, Laura L; Artuso, Lucia L; Bernardis, Isabella I; Parenti, Sandra S; Tenedini, Elena E; Ficarra, Guido G; Maiorana, Antonino A; Iannone, Anna A; Omarini, Claudia C; Moscetti, Luca L; Cristofanilli, Massimo M; Federico, Massimo M; Tagliafico, Enrico E
Publication Date: 2018-08-03

Variant appearance in text: ERBB2: P523L
PubMed Link: 30167082
Variant Present in the following documents:
  • Main text
  • oncotarget-09-31606.pdf
View BVdb publication page